:::SHILPA::::

Registered Office: [ No.39 5th Flr Lavanya Arcade- , Jayabheri Enclave Gachibowli , Ranga Reddy - 500032 , Telangana , India.
                                  Phone:+91 79979 91301   Fax:
                                  Email: cs@saiparenterals.com
                                  Website: https://www.saiparenterals.com

Initial public offer of 10,428,288 equity shares of face value of Rs5 each ("Equity Shares") of Sai Parenteral's Limited ("Company" or "Issuer") for cash at a price of Rs392 per equity share (Including a Share Premium of Rs387 Per Equity Share) ("Offer Price") aggregating to Rs408.79 Crore comprising a fresh issue of 7,270,408 equity shares of face value of Rs5 each aggregating to Rs285 Crore by the company ("Fresh Issue") and an offer for sale of 3,157,880 equity shares of face value of Rs5 each aggregating to Rs123.79 Crore ("Offered Shares") by investor selling shareholders (such sale, the "Offer For Sale", and together with the fresh issue, the"Offer"). The offer shall constitute 23.60% of the post-offer paid up equity share capital of the company. Price Band: Rs392 per equity share of face value of Rs5 each. The floor price is 78.40 times the face value of the equity shares. Bids can be made for a minimum of 38 equity shares of face value of Rs5 each and in multiples of 38 equity shares of face value of Rs5 each thereafter.

Issue		Money Payable On
Opens On	Closes On	Application	Allotment
24-Mar-26	27-Mar-26	Rs 392.00-0.00	Rs 0.00-0.00
Minimum Application for shares in Nos : 38 Further Multiples of : 38

	Rs Cr	Lead Managers to the Issue
Project Cost	256.50	Arihant Capital Markets Limited
Project Financed through Current Offer	408.79
Post Issue Equity Share Capital	22.09
Issue Price	Rs.392.00

Projects

Capacity expansion and upgradation of manufacturing facilities	Establishment of a new R&D Centre
Repayment / prepayment of certain outstanding borrowings	Working capital requirements
Investment in wholly owned subsidiary, Sai Parenterals Pte Limited (Singapore), in relation to the proposed acquisition of Noumed Pharmaceuticals Pty Limited (Australia)	General corporate purposes

Promoted By

Anil Kumar Karusala

Vijitha Gorrepati

Karusala Aruna

Listing At

BSE

NSE

Registrar to the Issue

No Data Found.

Site Map | Disclaimer | Margin Files | E-Contract Login |

Back Office Login search

Registered Office
B-11, 3rd Floor, Plot-36, Tamarind House, Mudhana Shetty Marg, Hutatma Chowk, Fort, Mumbai - 400 001
Existing customers can send in their Grievances to : investorgrievance@ssbpl.net '/ response@ssbpl.nets

SEBI Registration Details:

Shilpa Stock Broker Pvt. Ltd.: INZ000201636 | CIN No: U67120MH1999PTC118512 | IN-DP-487-2020 | Research Analyst: INH000000776 | BSE Enlistment No.-5047 Shikago Trade Pvt. Ltd.: INZ000042135

Designed, Developed and Maintained by CMOTS InfoTech (ISO 9001:2015 & ISO/IEC 27001:2022 Certified)